CELLINK signs agreement to extend its production site

CELLINK’s production is completed in-house without middlemen – this unique advantage enables a workflow with high quality assurance and short lead times. To meet rising demand and incorporate its expanding product portfolio in the production line, CELLINK has signed an agreement to extend its business operations onto a new premises where all production efforts will take place.

The new space is located in Gothenburg close to the CELLINK headquarters.

With the ever-rising demand for our products and an expanded product portfolio, it is a natural step in our strategic plan to expand our production site. Starting in January 2020, the size of our space will increase from 300 to 1900 square meters. This significant expansion will enable us to increase our production capacity while maintaining the high quality characteristic of CELLINK products.

Our team is very excited to move into a large and customized location. I am really proud of the entire team and the way it has grown since CELLINK began. We experienced an enormous increase in output this past year, and we’ve also placed a lot of focus on developing new ways to raise our quality standards even higher.”

Simon Rekonen, Global Production Manager

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CELLINK. (2020, January 02). CELLINK signs agreement to extend its production site. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20200102/CELLINK-signs-agreement-to-extend-its-production-site.aspx.

  • MLA

    CELLINK. "CELLINK signs agreement to extend its production site". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20200102/CELLINK-signs-agreement-to-extend-its-production-site.aspx>.

  • Chicago

    CELLINK. "CELLINK signs agreement to extend its production site". News-Medical. https://www.news-medical.net/news/20200102/CELLINK-signs-agreement-to-extend-its-production-site.aspx. (accessed November 21, 2024).

  • Harvard

    CELLINK. 2020. CELLINK signs agreement to extend its production site. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20200102/CELLINK-signs-agreement-to-extend-its-production-site.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CELLINK announces partnership with AstraZeneca to provide advanced 3D-bioprinted liver organoids